BSE filing, NSE: RRIL. Summary written from the filing by ALFA Finder's alert engine.
RRIL Ltd: key numbers
- Share price
- ₹15.19
- Market cap
- ₹184.1 Cr
- Revenue (annual)
- ₹122.0 Cr
- Net profit (annual)
- ₹8.67 Cr
- P/E (TTM)
- 20.5×Sector 49.5×
- Promoter holding
- 70.95%+0.02% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from RRIL Ltd
All →RRIL Other Announcement
RRIL Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026. This submission complies with Regulation 31(1)(b) of SEBI LODR.
RRIL Annual General Meeting
RRIL Limited held its 35th Annual General Meeting on September 25, 2026. Shareholders adopted financial statements and approved the re-appointment of a director.
RRIL Promoter Selling (Off-Market)
Promoter immediate relatives Harish and Rekha Jain gifted their stakes to Kiran Ratanchand Jain, who acquired the shares off-market.
RRIL Promoter Buying (Off-Market)
Kiran Ratanchand Jain acquired 58.51 lakh shares (4.83% stake) of RRIL Limited via an inter-se gift transfer from existing promoter group members.
- Promoter stake change
- +5.10%
RRIL Promoter Buying (Off-Market)
Mr. Kiran Ratanchand Jain, a promoter of RRIL Ltd, will acquire a 4.83% stake via gift from immediate relatives. This off-market inter-se transfer involves no consideration.
- Promoter stake change
- +4.83%
RRIL Annual Report
RRIL Limited has submitted its 35th Annual Report for the Financial Year 2025-26. The Annual General Meeting is scheduled for September 25, 2026, via video conferencing.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.